Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million
Go back to Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million| (NYSE: BHVN) | Delayed: 16.79 +0.15 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.64 | 52 Week High | $ | |||
| Open | $16.49 | 52 Week Low | $ | |||
| Day High | $17.28 | P/E | N/A | |||
| Day Low | $16.25 | EPS | $ | |||
| Volume | 2,101,049 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 57.96 -0.41 (0.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.37 | 52 Week High | $3.48 | |||
| Open | $58.54 | 52 Week Low | $0.80 | |||
| Day High | $58.84 | P/E | N/A | |||
| Day Low | $57.78 | EPS | $-1.54 | |||
| Volume | 3,322,552 | |||||
